United States · FDA National Drug Code directory
Tafluprost
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-339_9ebbfaa4-b3c0-46d2-bc83-9817b2d238df
- Product NDC
- 50742-339
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Tafluprost
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241218
- Source listing expiry
- 20261231
Source-listed ingredients
- TAFLUPROST — .015 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (50742-339-30) / 5 VIAL, SINGLE-DOSE in 1 POUCH (50742-339-05) / .3 mL in 1 VIAL, SINGLE-DOSE · 50742-339-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →